| Period Ending | Mar 30, 2013 | Mar 30, 2012 | Mar 30, 2011 |
|---|
|
Total Revenue
|
1,214,483
|
825,823
|
1,136,876
| | Cost of Revenue | 715,837 | 528,855 | 689,381 | | |
Gross Profit
|
498,646
|
296,968
|
447,495
| |
|
Operating Expenses |
|
Research Development | 78,184 | 64,162 | 69,576 |
|
Selling General and Administrative | 404,589 | 304,949 | 285,778 |
|
Non Recurring |
-
|
-
|
-
|
|
Others | 10,634 | 12,123 | 14,999 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
5,239
|
(84,266)
|
77,142
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 5,239 | (84,266) | 77,142 |
|
Interest Expense | 31,351 | 19,571 | 13,519 |
|
Income Before Tax | (26,112) | (103,837) | 63,623 |
|
Income Tax Expense | 5,050 | 3,863 | 9,819 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (31,162) | (107,700) | 53,804 | |
|
Non-recurring Events |
|
Discontinued Operations | 1,671 | (1,116) | (5,346) |
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(29,491)
|
(108,816)
|
48,458
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(29,491)
|
(108,816)
|
48,458
|
|